Back to
ProShare Advisors LLC
CPRX31 quarters
Position history for
ProShare Advisors LLC's holdings in CATALYST PHARMACEUTICALS INC
ProShare Advisors LLC holds 28,649 shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $900,439 as of 2026-Q2. The position was increased (+59.1% shares). CPRX represents 0.0% of ProShare Advisors LLC's portfolio.
Current Value
$900,439
Current Shares
28,649
Total Value Change
+$880,439
Total Shares Change
+18,488
Quarter-by-Quarter History
Other major holders of CPRX: BlackRock, Inc.